pyridostigmine bromide

Generic: pyridostigmine bromide

Labeler: oceanside pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine bromide
Generic Name pyridostigmine bromide
Labeler oceanside pharmaceuticals
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

pyridostigmine bromide 180 mg/1

Manufacturer
Oceanside Pharmaceuticals

Identifiers & Regulatory

Product NDC 68682-301
Product ID 68682-301_4823269e-594b-4f83-99ce-e9d2436bc5f1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA011665
Listing Expiration 2026-12-31
Marketing Start 1959-01-12

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68682301
Hyphenated Format 68682-301

Supplemental Identifiers

RxCUI
903847
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number NDA011665 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-301-30)
source: ndc

Packages (1)

68682-301-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-301-30)

Ingredients (1)

pyridostigmine bromide (180 mg/1)

Linked Drug Pages (1)

pyridostigmine bromide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4823269e-594b-4f83-99ce-e9d2436bc5f1", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903847"], "spl_set_id": ["7cf12f6c-4c6c-474b-895a-93151d657ca6"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-301-30)", "package_ndc": "68682-301-30", "marketing_start_date": "19590112"}], "brand_name": "pyridostigmine bromide", "product_id": "68682-301_4823269e-594b-4f83-99ce-e9d2436bc5f1", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "68682-301", "generic_name": "pyridostigmine bromide", "labeler_name": "Oceanside Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pyridostigmine bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "180 mg/1"}], "application_number": "NDA011665", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "19590112", "listing_expiration_date": "20261231"}